Tower Research Capital (TRC)’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.32K | Buy |
2,301
+279
| +14% | +$644 | ﹤0.01% | 4206 |
|
|
2025
Q1 | $15.8K | Sell |
2,022
-152
| -7% | -$1.19K | ﹤0.01% | 3203 |
|
|
2024
Q4 | $10.2K | Sell |
2,174
-908
| -29% | -$4.24K | ﹤0.01% | 3835 |
|
|
2024
Q3 | $16.6K | Buy |
+3,082
| New | +$16.6K | ﹤0.01% | 3354 |
|
|
2024
Q2 | – | Sell |
-2,255
| Closed | -$26.5K | – | 5839 |
|
|
2024
Q1 | $26.5K | Buy |
2,255
+721
| +47% | +$8.47K | ﹤0.01% | 2754 |
|
|
2023
Q4 | $17.3K | Sell |
1,534
-1,009
| -40% | -$11.4K | ﹤0.01% | 3745 |
|
|
2023
Q3 | $17.2K | Buy |
2,543
+973
| +62% | +$6.59K | ﹤0.01% | 3515 |
|
|
2023
Q2 | $14.3K | Sell |
1,570
-467
| -23% | -$4.24K | ﹤0.01% | 3689 |
|
|
2023
Q1 | $13K | Buy |
2,037
+534
| +36% | +$3.41K | ﹤0.01% | 3976 |
|
|
2022
Q4 | $10K | Sell |
1,503
-2,406
| -62% | -$16K | ﹤0.01% | 4016 |
|
|
2022
Q3 | $25K | Buy |
+3,909
| New | +$25K | ﹤0.01% | 3756 |
|
|
2022
Q1 | – | Sell |
-7,306
| Closed | -$75K | – | 6306 |
|
|
2021
Q4 | $75K | Buy |
+7,306
| New | +$75K | ﹤0.01% | 2436 |
|
|
2021
Q3 | – | Sell |
-1,401
| Closed | -$25K | – | 5950 |
|
|
2021
Q2 | $25K | Sell |
1,401
-11,964
| -90% | -$213K | ﹤0.01% | 3676 |
|
|
2021
Q1 | $159K | Buy |
+13,365
| New | +$159K | ﹤0.01% | 2194 |
|
|
2020
Q4 | – | Sell |
-600
| Closed | -$6K | – | 5268 |
|
|
2020
Q3 | $6K | Sell |
600
-755
| -56% | -$7.55K | ﹤0.01% | 4289 |
|
|
2020
Q2 | $7K | Buy |
+1,355
| New | +$7K | ﹤0.01% | 4149 |
|
|
2019
Q4 | – | Sell |
-204
| Closed | -$1K | – | 3913 |
|
|
2019
Q3 | $1K | Buy |
+204
| New | +$1K | ﹤0.01% | 3874 |
|